Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Kausch

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Oncology Reports|September 6, 2005
E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladderAnne Mahnken, Ingo Kausch, Alfred C Feller, et al.
Plos One|July 3, 2020
Oncoprotein 18 is necessary for malignant cell proliferation in bladder cancer cells and serves as a G3-specific non-invasive diagnostic marker candidate in urinary RNAMerle Hanke, Josephine Dubois, Ingo Kausch, et al.
Expert Review of Anticancer Therapy|December 21, 2004
Cytokine and vaccine therapy of kidney cancerChristian Doehn, Ingo Kausch, Steffi Melz, et al.
Current Opinion in Molecular Therapeutics|April 27, 2007
Drug evaluation: Therion's rV-PSA-TRICOM + rF-PSA-TRICOM prime-boost prostate cancer vaccineChristian Doehn, Ingo Kausch, Torsten Böhmer, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2008
Prostate cancer vaccines: current status and future potentialChristian Doehn, Torsten Böhmer, Ingo Kausch, et al.
Clinical Chemistry|October 9, 2007
Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/urokinase plasminogen activator to be a novel marker for bladder cancerMerle Hanke, Ingo Kausch, Gerlinde Dahmen, et al.
Urology|March 29, 2006
Mesonephroid adenocarcinoma arising from mesonephroid metaplasia of the urinary bladderHenrik Suttmann, Konstanze Holl-Ulrich, Melanie Peter, et al.
Lasers in Medical Science|January 19, 2011
Comparison between a 1.92-μm fiber laser and a standard HF-dissection device for nephron-sparing kidney resection in a porcine in vivo studyDirk Theisen-Kunde, Sönke Tedsen, Christian Doehn, et al.
BJU International|February 1, 2005
Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibitionIngo Kausch, Hai Jiang, Nina Ewerdwalbesloh, et al.
International Journal of Oncology|April 8, 2010
Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivoBeate Köberle, Claudia Ditz, Ingo Kausch, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Oncology Reports|September 6, 2005
E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladderAnne Mahnken, Ingo Kausch, Alfred C Feller, et al.
Plos One|July 3, 2020
Oncoprotein 18 is necessary for malignant cell proliferation in bladder cancer cells and serves as a G3-specific non-invasive diagnostic marker candidate in urinary RNAMerle Hanke, Josephine Dubois, Ingo Kausch, et al.
Expert Review of Anticancer Therapy|December 21, 2004
Cytokine and vaccine therapy of kidney cancerChristian Doehn, Ingo Kausch, Steffi Melz, et al.
Current Opinion in Molecular Therapeutics|April 27, 2007
Drug evaluation: Therion's rV-PSA-TRICOM + rF-PSA-TRICOM prime-boost prostate cancer vaccineChristian Doehn, Ingo Kausch, Torsten Böhmer, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2008
Prostate cancer vaccines: current status and future potentialChristian Doehn, Torsten Böhmer, Ingo Kausch, et al.
Clinical Chemistry|October 9, 2007
Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/urokinase plasminogen activator to be a novel marker for bladder cancerMerle Hanke, Ingo Kausch, Gerlinde Dahmen, et al.
Urology|March 29, 2006
Mesonephroid adenocarcinoma arising from mesonephroid metaplasia of the urinary bladderHenrik Suttmann, Konstanze Holl-Ulrich, Melanie Peter, et al.
Lasers in Medical Science|January 19, 2011
Comparison between a 1.92-μm fiber laser and a standard HF-dissection device for nephron-sparing kidney resection in a porcine in vivo studyDirk Theisen-Kunde, Sönke Tedsen, Christian Doehn, et al.
BJU International|February 1, 2005
Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibitionIngo Kausch, Hai Jiang, Nina Ewerdwalbesloh, et al.
International Journal of Oncology|April 8, 2010
Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivoBeate Köberle, Claudia Ditz, Ingo Kausch, et al.
Pageof 3